###### Strengths and limitations of this study

-   This study will evaluate the protective effects of Tai Chi exercise on ischaemic stroke risk in an elderly community population with risk factors for ischaemic stroke.

-   A prospective, randomised controlled study with blinded outcome measurements will be performed.

-   Indirect and non-clinical end point measurements will be used to judge the protective effects of Tai Chi on ischaemic stroke risk.

-   There have been insufficient samples and observation periods to investigate concrete outcomes (mortality, incidence of ischaemic stroke event).

Introduction {#s1}
============

Stroke is one of the most common causes of mortality and disability in adults worldwide, and it represents a large socioeconomic burden in most countries.[@R1] [@R2] Globally, 15 million people suffer from an episode of stroke annually, and 5 million of these people are left permanently disabled.[@R3] Despite mortality rates attributable to stroke gradually decreasing and having plateaued over the past 30 years in industrialised countries, due to the development of therapeutic strategies, the efficacy of primary or secondary prevention is often unsatisfactory.[@R4] [@R5] Thus, the absolute numbers of cases of stroke and its disability burden will be dramatically increased over the next two decades with globally increasing life expectancy.[@R6] Currently, therefore, stroke remains a large health burden worldwide.

The aetiology of stroke is multifactorial, and the key to stroke prevention is in the treatment of the major risk factors for stroke. Currently, more than 100 risk factors, which have been classified as non-modifiable, modifiable or potentially modifiable factors, have been identified as contributors to the pathogenetic progression of ischaemic stroke.[@R7] [@R8] Non-modifiable risk factors (eg, age, sex, ethnicity, low weight at birth, inherited diseases) usually serve as markers for high stroke risk, whereas modifiable risk factors, such as hypertension, diabetes mellitus, dyslipidaemia, waist-to-hip ratio, plasma inflammatory factors, dietary risk factors, asymptomatic cerebral or carotid stenosis and lack of physical activity, are amenable to intervention to decrease stroke risk.[@R9] [@R10] Compelling results from clinical trials have indicated that control of risk factors markedly diminished the risk of stroke.[@R11] [@R12] However, the optimal management of risk factors has remained limited.

Increasing evidence has shown that exercise is an effective intervention to prevent stroke and other cardiovascular and cerebrovascular diseases (CVDs). Exercise benefits include controlling the risk factors for stroke by decreasing obesity, hypertension, dyslipidaemia and the development of diabetes.[@R13] [@R14] However, most of these health benefits occur with at least 150 min/week of moderate intensity, or 75 min/week of vigorous intensity of exercise.[@R15] The prevalence of such exercise in the elderly is quite low; in addition, appropriate forms are scarce for elderly people because ageing is usually accompanied by a significant decline in organ function.[@R16] [@R17]

Tai Chi, as a traditional Chinese mind-body exercise, has been practiced for several centuries in China and has also spread to Western countries over the past 20 years. It consists of a series of slow but continuous movements, which keep breathing and imagery in close cooperation. Through the combination of breathing and movements, the practitioner can achieve efficiency of 'body relaxation and mind calm'.[@R18] [@R19] Tai Chi is practiced in a semisquatting position, but the exercise intensity can be easily adjusted by controlling the speed and postural height; therefore, it is especially feasible for elderly people.

Tai Chi has been shown to have a variety of physical and psychological effects. For example, Tai Chi can help to improve body balance and physical fitness,[@R20] and reduce depression and anxiety,[@R21] and it is effective for fall prevention in elderly adults.[@R22] As an accessible and cost-effective form of exercise, Tai Chi is increasingly popular for elderly people, and it might be an important intervention for the primary and secondary prevention of CVD. In fact, previous studies have demonstrated that regular Tai Chi training was effective in reducing blood pressure,[@R23] preventing diabetes[@R24] and improving dyslipidaemia,[@R25] [@R26] which are determinants of stroke. Furthermore, several studies have shown Tai Chi to be helpful for aerobic capacity,[@R27] cerebrovascular compliance and cardiorespiratory function,[@R28] which are important because cardiac-cerebral vascular dysfunction is believed to a potential mechanism involved in the pathophysiological process of CVD.[@R29] [@R30] A recent Cochrane systematic review suggested the probable beneficial effects of Tai Chi on CVD risk factors.[@R31] Therefore, current evidence has concluded that Tai Chi is likely to protect against ischaemic stroke risk in the elderly community population, especially those people with risk factors for ischaemic stroke. As a result, we designed a randomised controlled trial of Tai Chi versus usual physical activity in the elderly community population with risk factors for ischaemic stroke. We hypothesise that individuals with high risk of ischaemic stroke who receive a 12-week Tai Chi exercise programme will have greater improvement in controlling risk factors for ischaemic stroke, and enhancing cerebrovascular and cardiopulmonary function, than those who maintain their usual physical activity as assessed immediately after the 12-week Tai Chi exercise intervention, and that these benefits will be sustained until the end of a 12-week follow-up. The aim is to demonstrate that, compared with usual physical activity, Tai Chi has protective effects against ischaemic stroke risk and is a suitable exercise for the elderly community population with risk factors for ischaemic stroke.

Materials and methods {#s2}
=====================

Study design {#s2a}
------------

This is a randomised, parallel, controlled trial to explore the effects of Tai Chi on ischaemic stroke risk in those in the elderly community with risk factors for ischaemic stroke by comparing a Tai Chi exercise intervention with usual physical activities. The elderly individuals who were randomly allocated to the Tai Chi group will undergo a 12-week Tai Chi exercise intervention with a frequency of 1 h/day for 5 days/week, based on their usual physical activities. The elderly people in the control group will not receive any specific exercise intervention (ie, they will maintain their usual, original physical activities habits). Primary or secondary outcomes will be measured at baseline, postintervention and after the follow-up period.

Participants {#s2b}
------------

According to 'The 2012 Annual Screening and Intervention Project Workbook for the High Risk Stroke Population', the participants with a high risk of ischaemic stroke must meet two items from items 1--7 and item 8: Current high blood pressure (systolic/diastolic pressure ≥140/90 mm Hg) or taking antihypertensive drugs;Atrial fibrillation;Currently smoking (at least one cigarette each day for 1 year);Dyslipidaemia;Diabetes mellitus;Obvious overweight or obesity (body mass index (BMI) ≥24 kg/m^2^);A family history of stroke (a stroke history in 3 generations);A history of transient ischaemic attack.

To be eligible, the participant must meet the following criteria.

### Inclusion criteria {#s2b1}

1.  Confirmed individuals with high risk or ischaemic stroke

2.  No regular exercise for at least the past 1 year (regular exercise is defined as lasting more than 3 months with a frequency of 30 min or more, at least 1--3 times/week)

3.  Male or female aged between 55 and 70 years

4.  Informed consent.

### Exclusion criteria {#s2b2}

Participants who reported one of the following conditions were excluded: History of stroke;Suffering from severe CVDs, musculoskeletal system diseases or other sports contraindications;Communication disorder.

Recruitment {#s2c}
-----------

Participants were recruited through community advertisements, posters and leaflets at a free clinic in a community centre in Gulou district, Fuzhou city. Two of the investigators contacted each individual who was interested in more information or who responded to the recruitment information. The investigators fully explained the study, including all of the potential benefits and risks. The participants were allowed to ask the investigators any questions prior to signing the informed consent statement. The investigator witnessed the informed consent statement after the participant signed and dated it. All of the participants provided informed consent prior to baseline measurements.

Randomisation and concealment of allocation {#s2d}
-------------------------------------------

The eligible participants were randomly allocated to either the Tai Chi exercise group or the control group at a 1:1 ratio. A random allocation sequence was created using the PLAN procedure in SAS statistical software (V.9.1) by a statistician who was not involved in this trial at the Center for Evidence-based Chinese Medicine, Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine. Then, the allocation sequence was kept by a research assistant who was not involved in the recruitment, intervention, outcomes assessment or statistical analysis. After the participants met the study criteria and completed all of the baseline assessments, they were informed of their group allocation (either the Tai Chi or control group) by the research assistant, via telephone.

Blinding {#s2e}
--------

Blinding of the participants and Tai Chi instructor was impossible in this study because they both knew the allocation result when Tai Chi training began. However, the outcome collectors and statistical analysts were blinded. Two types of blinding codes were kept by the research assistant. With the first blinding code, the allocation results were replaced by the letter A or B, and the real meaning of the letter A or B was marked using the second blinding code. The research assistant will deliver letter A or B to the statistician after the database is closed and declare the real meaning of the letter A or B when all of the analysis of the data is completed.

Intervention {#s2f}
------------

### Tai Chi training {#s2f1}

The 24 forms of simplified Tai Chi Chuan, which has been recommended as a popular, healthy sport by the Chinese National Sports Commission since 1956,[@R32] will be performed by the participants in the Tai Chi group. Participants will gather at a community centre and practice Tai Chi Chuan. The training regime of 5 sessions per week and 60 min per session for 12 weeks will be taught by certified instructors who have engaged in teaching Tai Chi Chuan for at least 5 years at Fujian University of Traditional Chinese Medicine. Sixty minutes of training time will include a 10 min warm up, 45 min practice and refinement, and a 5 min cool down. The 'meditation through movement' art of Tai Chi Chuan, including relaxation, breathing skills and coordinated movement of the arms, legs and body, as well as the philosophic opinions of Tai Chi Chuan, will be provided to the participants in the Tai Chi group. The 24 forms of simplified Tai Chi Chuan are shown in [figure 1](#BMJOPEN2015009158F1){ref-type="fig"}.

![Specification of 24 forms of simplified Tai Chi Chuan.](bmjopen2015009158f01){#BMJOPEN2015009158F1}

### Usual physical activities {#s2f2}

The control group will maintain its original usual physical activities, which normally include housework, daily living activities, slow walking, shopping and babysitting, and they will not receive any regular exercise intervention during the 12-week intervention period.

Study supervision {#s2g}
-----------------

The research assistant will record the daily attendance of the Tai Chi group and will investigate causes of absenteeism by telephone. The Tai Chi instructors will supervise participants' compliance in the Tai Chi group and correct the postures for Tai Chi movement during training. In addition, to analyse the impact of exceeding the usual physical activities, all of the participants in the Tai Chi group and the usual physical activities group, will be required to record their activity in logs, in which the duration and intensity of their activities for the whole day will be classified into three sections, including the durations of low-intensity activities, moderate-intensity activities and high-intensity activities.

Follow-up {#s2h}
---------

After the 12-week intervention period, all of the participants will enter a 12-week unsupervised follow-up period, during which the participants in the Tai Chi group will return to their original lifestyles. All of the participants will be required to record their daily physical activity information on the physical activity form. The research assistant will go to each participant\'s home to collect these forms.

Measurements {#s2i}
------------

[Table 1](#BMJOPEN2015009158TB1){ref-type="table"} provides a brief summary of the types and schedules for the conduct of all of the assessments in the study. The primary outcomes consist of cerebral haemodynamic parameters. Secondary outcomes include cardiopulmonary function (resting pulmonary function, cardiac structure and function), plasma risk indicators of CVD (blood lipid, fasting blood glucose and homocysteine), motor capability (balance function, lumbar and lower limb proprioception function, 6 min walk test), physical parameters (body mass index, waist-to-hip ratio, sit-and-reach, one foot stand with eyes closed) and psychological outcomes (health-related quality of life, quality of sleep and mood). All of the measurements will be obtained by personnel blinded to participants' randomisation allocation.

###### 

Brief description of outcome assessments

                                                     Recruitment   Post-training   Post follow-up
  -------------------------------------------------- ------------- --------------- ----------------
  Demographic characteristics                        **×**                         
  Cerebral haemodynamic parameters                   **×**         **×**           **×**
  Cardiopulmonary function                                                         
   Cardiac structure and function                    **×**         **×**           **×**
   Resting pulmonary function                        **×**         **×**           **×**
  Plasma risk indicators of cardiovascular disease                                 
   Blood lipid                                       **×**         **×**           **×**
   Fasting blood glucose                             **×**         **×**           **×**
   Homocysteine                                      **×**         **×**           **×**
  Motor capability                                                                 
   Balance function                                  **×**         **×**           **×**
   Lower limbs proprioception function               **×**         **×**           **×**
  Physical parameters                                                              
   Body mass index                                   **×**         **×**           **×**
   Waist-to-hip ratio                                **×**         **×**           **×**
   6 min walk test                                   **×**         **×**           **×**
   Sit-and-reach                                     **×**         **×**           **×**
   Time for one foot standing with eyes closed       **×**         **×**           **×**
  Psychological outcomes                                                           
   Health-related quality of life                    **×**         **×**           **×**
   Quality of sleep                                  **×**         **×**           **×**
   Mood                                              **×**         **×**           **×**
  Safety assessments                                               **×**           

### Primary outcome measurements {#s2i1}

Cerebral haemodynamic parameters will include maximum blood flow velocity (V~max~), minimum blood flow velocity (V~min~), mean blood flow velocity (V~mean~), pulsatility index (PI) and vascular resistance index (RI). The bilateral vertebral artery (VA), bilateral middle cerebral artery (MCA), bilateral anterior cerebral artery (ACA) and bilateral posterior cerebral artery (PCA) of the brain and the basilar artery (BA) will be measured using a colour Doppler ultrasound imaging device (Philips, product type: IU22) by the professional operators at Fujian University of Traditional Chinese Medicine Subsidiary Rehabilitation Hospital.

### Secondary outcome measurements {#s2i2}

-   *Cardiopulmonary function:* Including cardiac structure, and function and static lung function. *Cardiac structure and function:* Cardiac structure and function including aortic diameter, left atrial diameter, interventricular septum thickness, left ventricular diastolic diameter, left ventricular posterior wall thickness, left ventricular anterior wall thickness, right atrial diameter, right ventricle diameter, main pulmonary artery diameter and left ventricular fraction, will be measured using a colour Doppler ultrasound imaging device (product type: Siemans Acuson X300) by the professional operators at the Health Check Center of the Second People\'s Hospital of Fujian Province.*Static lung function*: Static lung function includes vital capacity MAX (VC MAX), forced expiratory volume in 1 s (FEV1), FEV1%FVC (forced vital capacity), and maximal voluntary ventilation (MVV), which will be measured using a cardiopulmonary function instrument (Jaeger, Germany, product type: OXYCON PRO PC) by the professional operators at Fujian University of Traditional Chinese Medicine Subsidiary Rehabilitation Hospital.

-   *Plasma risk factor indicators:* Plasma risk factor indicators include total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL) and high-density lipoprotein (HDL), fasting blood glucose (FBG) and homocysteine (HCY). Blood profiles will be measured according to the specifications of the fasting period. Blood samples will be collected at Fujian University of Traditional Chinese Medicine Subsidiary Rehabilitation Hospital. Standardised measurements of TC, TG, FBG and HCY will be performed using the enzymatic method. The clearance method will be applied to measure plasma LDL levels; in addition, plasma HDL levels will also be measured by the inhibition method.

-   *Motor capability*: The motor capability involved in balance and proprioception function will be measured using *Prokin* systems (product type: PK254P), produced by Italy Tecnobody Srl, at Fujian University of Traditional Chinese Medicine Subsidiary Rehabilitation Hospital.

-   *Physical parameters:* Physical parameters consist of BMI, waist-to-hip ratio (WHR), flexibility, 6 min walk test (6MWD) and time on one foot standing with eyes closed. BMI will be assessed using a body scale. Waist-to-hip ratio will be tested using a metric ruler. Flexibility will be measured with the 'sit and reach' test, using a 'sit and reach' tester produced by *Zhongtitongfang Co, Ltd, Beijing* (product type: CSTF-TQ-5000). All of the above measurements will be performed by the outcome assessors blinded to the participants' randomisation assignments.

-   *Psychological outcomes*: Psychological outcomes include health-related quality of life, quality of sleep and mood. *Health-related quality of life:* Health-related quality of life will be assessed using the Chinese version of the SF-36 scale.[@R33] This scale consists of 36 items to assess eight health concepts: Physical Functioning (PF) (10 items), Role Physical (RP) (4 items), Bodily Pain (BP) (2 items), General Health (GH) (5 items), Vitality (VT) (4 items), Social Functioning (SF) (2 items), Role Emotional (RE) (3 items) and Mental Health (MH) (5 items).[@R34] The Chinese version of the SF-36 has been reported to be reliable, including split-half reliability, internal consistency, criterion validity and structure validity, by Jin and Yu.[@R35]*Quality of sleep:* Quality of sleep will be evaluated using the Pittsburgh Sleep Quality Index (PSQI), which is a self-rated questionnaire to assess sleep quality within 1 month.[@R36] Nineteen items generate seven dimensions: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication and daytime dysfunction.[@R37] Acceptable internal consistency, construct validity, criterion-related validity and the test--retest reliability of the Chinese version of the PSQI have been demonstrated.[@R38] [@R39]*Mood*: Mood will be assessed by the Profile of Mood States Short Form (POMS-SF), which was proven to be an excellent measure of affective mood state fluctuation in a wide variety of populations with stronger reliability and validity.[@R40] The Chinese version of the BPOMS has been reported to have acceptable internal consistency, construct validity and criterion-related validity, by Song and Wen.[@R41]

### Safety assessments {#s2i3}

Any expected or unexpected adverse events related to the Tai Chi intervention will be reported to research assistants and recorded on case report forms. All adverse events will be analysed for causality due to the Tai Chi intervention. Serious adverse events will be reported to the primary researchers and ethics committee. The primary researchers and ethics committee will assess their severity and make a decision regarding whether the participant needs to withdraw from this study.

Data management {#s2j}
---------------

The data are collected through the print-based case report forms (p-CRFs) written by the outcomes assessors and entered into Web-based case report forms (w-CRFs) at electronic data capture (EDC) systems by research assistants. The integrity of data will be enforced when the data are entered into w-CRFs by means of checks on value ranges and logical checks. The EDC system and Web servers are hosted in the centre for data management of FJTCM, and they meet the available standards for security (<http://210.34.74.191/srtp/users/loginlangth.action>). The participants' data from w-CRFs will be stored in the EDC system in separate password-protected locations.

Access to and exporting of w-CRFs data are limited to those data management staff working in the centre for data management who are not involved in the conduct of the trial. Final data cleaning, data locking and data analysis will be performed at the centre for data management. All data management will be undertaken without access to the randomisation allocation sequence.

Sample size calculation {#s2k}
-----------------------

The sample size was calculated using the data from a reference that investigated cerebral haemodynamic parameters among people in the elderly community who have ischaemic stroke risk, using a colour Doppler ultrasound imaging device.[@R42] Owing to the lack of availability of previous studies focusing on Tai Chi exercise for cerebral haemodynamic parameters, we anticipate an average of 10% improvement in cerebral haemodynamic parameters among participants undergoing the 12-week Tai Chi training compared with those participants performing their usual physical activities, based on the consideration of clinical significance. According to data on cerebral haemodynamic parameters in the reference,[@R34] the maximum sample size of 74 in each group was required for 80% power and two-sided significance α level of 0.05 to detect a difference of 3.2 mL/min in average blood flow velocity of the BA and to assume an SD of 6 mL/min (a mean of 32 mL/min and SD of 6 mL/min in average blood flow velocity of the BA was reported in another reference[@R42]). In anticipation of a 15% dropout rate, the optimal simple size would be 85 per group.

Statistical analysis {#s2l}
--------------------

The continuous variables will be expressed using means with SDs or medians with interquartile ranges for non-normal distributions. The categorical variables will be expressed as appropriate. Statistical comparisons between the groups in baseline characteristics were analysed using the t test or the Mann-Whitney test for continuous variables and Pearson\'s χ^2^ test or Fisher\'s exact test for categorical variables.

The primary analysis will compare the changes in cerebral haemodynamic parameters from baseline to the end point of the follow-up period between the comparison groups, using repeated analysis of variance (ANOVA) or analysis of covariance, adjusting by the cerebral haemodynamic parameter baseline values.

Secondary analyses will assess changes in secondary outcomes from baseline to the endpoint of the follow-up period between the Tai Chi group and the control group. All of the analyses will follow the template for the primary outcomes.

Primary and secondary analyses will be based on the intension-to-treat (ITT) principle, and the missing data will be imputed using the multiple imputation method. Subgroup analysis, stratified by characteristics of the risk factors for ischaemic stroke, will be used for the primary outcomes. Adverse events will be listed and analysed using the χ^2^ test or Fisher\'s exact test. All of the statistical tests will be performed using IBM SPSS (IBM Inc, Chicago, Illinois, USA) V.21.0 statistical software packages. Statistical significance will be defined as a two-sided p value of ≤0.05.

Ethics and dissemination {#s2m}
------------------------

All of the participants provided written informed consent before being enrolled.

The study will be conducted according to the Declaration of Helsinki. The findings of this study will be communicated to healthcare professionals, the participants and the public through peer-reviewed publications or scientific conferences.

Baseline results {#s2n}
----------------

Recruitment began in October 2014 and was completed in March 2015. A total of 2176 individuals were screened for eligibility: 438 participants did not meet the inclusion criteria, 526 were excluded due to the exclusion criteria and 1042 were unwilling to participate in the study. Finally, a total of 170 eligible participants were randomised into the study. The flow of the participants through the recruitment process and randomisation is shown in [figure 2](#BMJOPEN2015009158F2){ref-type="fig"}.

![Flow chart of participants' recruitment and trial design.](bmjopen2015009158f02){#BMJOPEN2015009158F2}

[Table 2](#BMJOPEN2015009158TB2){ref-type="table"} lists the baseline characteristics collected at recruitment from the 170 participants. As shown, the randomisation of the two groups of participants with high risk of ischaemic stroke with similar characteristics had no differences in baseline demographic characteristics, including age, blood pressure, height, body weight, average daily moderate activity time, sex, nationality, marital status or level of education. In addition, no differences in history of diseases, family history of stroke, drinking or smoking were noted.

###### 

Baseline demographic characteristics of participants between Tai Chi group and control group

  -------------------------------------------------------------------------------------------------------------------------------------
  Variable                                           Tai Chi group\         Usual physical activity group\   T value (χ^2^)   p Value
                                                     (n=85)                 (n=85)                                            
  -------------------------------------------------- ---------------------- -------------------------------- ---------------- ---------
  Age, years (mean±SD)                               61.01±5.20             60.73±6.05                       0.326            0.744

  Seated systolic BP, mm Hg (mean±SD)                133.81±16.74           129.04±15.94                     1.906            0.058

  Seated diastolic BP, mm Hg (mean±SD)               77.74±9.28             76.35±10.48                      0.914            0.362

  Height, cm (mean±SD)                               160.41±7.42            159.70±7.46                      0.622            0.534

  Body weight, kg (mean±SD)                          65.312±9.53            64.14±10.90                      0.744            0.458

  Average daily activity time, h (median, 25--75%)   4.429 (6.964--2.071)   4.857 (6.892--2.857)             −0.577           0.564

  Gender (n, %)                                                                                                               

   Male                                              28 (32.9)              24 (28.2)                        0.443            0.506

   Female                                            57 (67.1)              61 (71.8)                                         

  Nationality (n, %)                                                                                                          

   Han nationality                                   84 (99.8)              85 (100)                         1.006            0.316

   Minority nationality                              1 (0.2)                0 (0)                                             

  Marital (n, %)                                                                                                              

   Married                                           79 (92.9)              80 (94.1)                        1.406            0.495

   Widowed                                           6 (7.1)                4 (4.7)                                           

   Divorced                                          0 (0)                  1 (1.2)                                           

  Lever of education (n, %)                                                                                                   

   Primary school                                    11 (12.9)              19 (22.4)                        7.681            0.053

   Junior high school                                33 (38.8)              18 (21.2)                                         

   Senior high school                                25 (29.5)              33 (38.8)                                         

   High school or above                              16 (18.8)              15 (17.6)                                         

  History of heart disease (n, %)                                                                                             

   Yes                                               9 (10.6)               14 (16.5)                        1.257            0.262

   No                                                76 (89.4)              71 (83.5)                                         

  History of diabetes (n, %)                                                                                                  

   Yes                                               8 (9.4)                11 (12.9)                        0.533            0.465

   No                                                77 (90.6)              74 (87.1)                                         

  History of hypertension (n, %)                                                                                              

   Yes                                               39 (45.9)              38 (44.7)                        0.024            0.878

   No                                                46 (54.1)              47 (55.3)                                         

  History of dyslipidaemia (n, %)                                                                                             

   Yes                                               50 (58.8)              53 (62.4)                        0.222            0.638

   No                                                35 (41.2)              32 (37.6)                                         

  Family history of stroke (n, %)                                                                                             

   Yes                                               16 (18.8)              15 (17.7)                        0.039            0.843

   No                                                69 (81.2)              70 (82.3)                                         

  Smoking (n, %)                                                                                                              

   Yes                                               11 (12.9)              15 (17.7)                        0.726            0.394

   No                                                74 (87.1)              70 (82.3)                                         

  Drinking (n, %)                                                                                                             

   Yes                                               23 (27.1)              28 (32.9)                        0.700            0.403

   No                                                62 (72.9)              57 (67.1)                                         
  -------------------------------------------------------------------------------------------------------------------------------------

BP, blood pressure.

[Tables 3](#BMJOPEN2015009158TB3){ref-type="table"} and [4](#BMJOPEN2015009158TB4){ref-type="table"} display the baseline data of the primary and secondary outcomes of the study samples. No differences between the Tai Chi and control groups were observed in cerebral haemodynamic parameters, cardiac structure and function, static lung function, plasma risk factors, balance and proprioception capability, physical parameters, Pittsburgh sleep quality index or Profile of Mood States Short Form, but SF-36 Physical component and Mental component summary scores in the Tai Chi group were slightly higher than those in the control group. Overall, the randomisation process established two groups of participants with similar baseline characteristics.

###### 

Baseline cerebral haemodynamic parameters between Tai Chi group and usual physical activities group

  Variables                         Tai Chi group   Usual physical activity group   T value/Z value/χ^2^ value   p Value                         
  --------------------------------- --------------- ------------------------------- ---------------------------- ---------------------- -------- -------
  Basilar artery                                                                                                                                 
   V~max~, cm/s                     82              65.89±17.62                     85                           62.84±16.57            1.155    0.250
   V~min~, cm/s                     82              59.34±16.55                     85                           56.71±15.42            1.065    0.288
   V~mean~, cm/s                    82              62.57±16.75                     85                           59.91±15.98            1.053    0.294
   PI                               82              0.92±0.19                       85                           0.95±0.25              −0.902   0.368
   RI                               82              0.57±0.07                       85                           0.58±0.09              −0.593   0.554
   Missing\*                        3                                               0                                                            0.246
  Left vertebral artery                                                                                                                          
   V~max~, cm/s                     82              59.0 (68.25--46.0)              85                           56.0 (69.0--45.5)      −0.463   0.644
   V~min~, cm/s                     82              52.0 (59.75--40.0)              85                           49.0 (60.0--39.0)      −0.608   0.543
   V~mean~, cm/s                    82              56.0 (63.50--43.0)              85                           52.0 (66.0--41.5)      −0.453   0.650
   PI                               82              0.91±0.19                       85                           0.94±0.21              −1.223   0.223
   RI                               82              0.56±0.07                       85                           0.57±0.08              −1.291   0.198
   Missing\*                        3                                               0                                                            0.246
  Right vertebral artery                                                                                                                         
   V~max~, cm/s                     82              59.32±16.95                     82                           58.13±16.12            0.458    0.648
   V~min~, cm/s                     82              52.37±15.51                     82                           51.06±14.65            0.554    0.580
   V~mean~, cm/s                    82              55.73±16.12                     82                           54.72±15.26            0.413    0.680
   PI                               82              0.93±0.20                       82                           0.97±0.19              −1.346   0.180
   RI                               82              0.57±0.07                       82                           0.58±0.07              −1.348   0.180
   Missing                          3                                               3                                                   0        1.0
  Left anterior cerebral artery                                                                                                                  
   V~max~, cm/s                     60              80.57±20.17                     69                           82.78±18.73            −0.647   0.519
   V~min~, cm/s                     60              71.5 (81.75--60.0)              69                           76.00 (89.00--58.50)   1.037    0.300
   V~mean~, cm/s                    60              75.0 (84.75--64.0)              69                           78.00 (92.50--64.50)   −1.013   0.311
   PI                               60              0.86±0.17                       69                           0.90±0.20              −1.397   0.165
   RI                               60              0.54±0.07                       69                           0.56±0.08              −1.283   0.202
   Missing                          25                                              16                                                  2.604    0.107
  Right anterior cerebral artery                                                                                                                 
   V~max~, cm/s                     55              80.0 (95.00--64.0)              55                           77.0 (94.0--68.0)      −0.006   0.995
   V~min~, cm/s                     55              73.49±20.53                     55                           72.44±19.66            0.275    0.784
   V~mean~, cm/s                    55              77.38±21.00                     55                           76.04±19.53            0.348    0.729
   PI                               55              0.85±0.15                       55                           0.90±0.20              −1.472   0.144
   RI                               55              0.54±0.06                       55                           0.56±0.08              −1.859   0.066
   Missing                          30                                              30                                                  0        1.0
  Left middle cerebral artery                                                                                                                    
   V~max~, cm/s                     60              93.27±21.59                     71                           94.65±21.65            −0.364   0.716
   V~min~, cm/s                     60              85.37±20.87                     71                           87.58±21.00            −0.603   0.548
   V~mean~, cm/s                    60              89.08±20.72                     71                           90.72±21.26            −0.444   0.658
   PI                               60              0.88±0.15                       71                           0.92±0.19              −1.199   0.233
   RI                               60              0.55±0.06                       71                           0.57±0.07              −1.199   0.265
   Missing                          25                                              14                                                  4.026    0.045
  Right middle cerebral artery                                                                                                                   
   V~max~, cm/s                     55              90.95±24.31                     63                           96.38±21.15            −1.299   0.197
   V~min~, cm/s                     55              83.44±23.29                     63                           87.79±20.75            −1.075   0.285
   V~mean~, cm/s                    55              87.71±24.07                     63                           91.79±21.03            −0.984   0.327
   PI                               55              0.87±0.13                       63                           0.88±0.16              −0.486   0.628
   RI                               55              0.55±0.07                       63                           0.55±0.06              −0.257   0.797
   Missing                          30                                              22                                                  1.773    0.183
  Left posterior cerebral artery                                                                                                                 
   V~max~, cm/s                     61              51.26±9.87                      68                           53.31±11.92            −0.869   0.387
   V~min~, cm/s                     61              46.26±9.01                      68                           47.21±11.13            −0.525   0.600
   V~mean~, cm/s                    61              49.00±9.41                      68                           50.12±11.46            −0.601   0.549
   PI                               61              0.91±0.15                       68                           0.93±0.19              −0.622   0.535
   RI                               61              0.56±0.06                       68                           0.57±0.07              −0.558   0.578
   Missing                          24                                              17                                                  1.575    0.209
  Right posterior cerebral artery                                                                                                                
   V~max~, cm/s                     57              51.07±11.21                     54                           50.89±10.73            0.087    0.931
   V~min~, cm/s                     57              44.46±9.80                      54                           44.87±9.43             −0.227   0.821
   V~mean~, cm/s                    57              47.72±10.27                     54                           48.15±10.20            −0.221   0.826
   PI                               57              0.88±0.16                       54                           0.92±0.17              −1.117   0.267
   RI                               57              0.55±0.06                       54                           0.56±0.07              −1.010   0.315
   Missing                          28                                              31                                                  0.234    0.629

Missing\*, Fisher\'s exact test; Missing, Pearson\'s χ^2^ test; PI, pulsatility index; RI, resistance index; V~max~, maximum blood flow velocity; V~mean~, mean blood flow velocity; V~min~, minimum blood flow velocity.

###### 

Baseline comparison of secondary outcomes between Tai Chi and usual physical activities group

  Variables                          Tai Chi group   Usual physical activity group   T(Z) value   p Value                         
  ---------------------------------- --------------- ------------------------------- ------------ ---------------------- -------- -------
  Cardiac structure and function                                                                                                  
   AOD, cm                           85              2.73±0.32                       85           2.77±0.34              −0.748   0.456
   LAD, cm                           85              3.17±0.46                       85           3.18±0.52              −0.158   0.874
   IVST, cm                          85              1.03±0.14                       85           1.02±0.15              0.477    0.634
   LVDD, cm                          85              4.38±0.51                       85           4.38±0.40              0.050    0.960
   LVPWT, cm                         85              0.94±0.11                       85           0.93±0.11              0.707    0.480
   LVAWT, cm                         85              1.03±0.12                       85           1.03±0.13              −0.176   0.861
   RAD, cm                           85              3.14 (3.34--2.95)               85           3.06 (3.32--2.85)      −1.052   0.293
   RVID, cm                          85              2.96±0.35                       85           2.97±0.35              −0.307   0.759
   MPAD, cm                          85              2.05±0.20                       85           2.09±0.27              −1.106   0.270
   LVEF, %                           85              62.0 (65.5--58.5)               85           63.0 (65.0--60.0)      −0.866   0.387
  Static lung function                                                                                                            
   VC~max~, L                        83              2.97±0.69                       82           2.86±0.70              1.074    0.285
   FEV1, L                           83              2.40±0.55                       82           2.31±0.59              1.018    0.310
   FEV1%FVC                          83              88.18 (91.65--83.50)            82           87.51 (92.39--83.69)   −0.018   0.986
   MVV, L/min                        83              78.96 (100.34--66.74)           82           86.03 (107.0--72.2)    −1.142   0.253
   Missing                           2                                               3                                            
  Plasma risk factor indexes                                                                                                      
   TC, mmol/L                        85              5.58±1.05                       85           5.52±1.17              0.357    0.772
   TG, mmol/L                        85              1.30 (1.73--0.95)               85           1.23 (1.65--0.98)      −0.168   0.866
   LDL, mmol/L                       85              3.62±0.90                       85           3.76±1.09              −0.931   0.353
   HDL, mmol/L                       85              1.34 (1.62--1.15)               85           1.27 (1.51--1.08)      −1.298   0.194
   FBG, mmol/L                       85              5.41 (5.82--5.06)               85           5.37 (6.06--5.09)      −0.323   0.747
   HCY, μmol/L                       85              10.80 (12.80--8.42)             85           9.82 (12.70--8.25)     −1.085   0.278
  Balance capability                                                                                                              
   Opened eyes perimeter, mm         85              278.0 (347.0--233.5)            85           267.0 (322.5--213.5)   −1.220   0.222
   Closed eyes perimeter, mm         85              480.0 (594.0--359.0)            85           418.0 (563.0--346.5)   −1.577   0.115
   Opened eyes ellipse area, mm^2^   85              228.0 (324.5--167.0)            85           241.0 (362.0--160.0)   −0.249   0.803
   Closed eyes ellipse area, mm^2^   85              494.0 (768.0--344.0)            85           533.0 (722.0--354.0)   −0.185   0.853
  Proprioception capability                                                                                                       
   ATE of right lower limb           85              39.0 (58.5--31.5)               85           39.0 (58.5--31.5)      −0.708   0.479
   ATE of left lower limb            85              36.0 (49.0--28.5)               85           39.0 (56.0--27.5)      −0.874   0.382
   ATE of waist clockwise            85              48.0 (79.0--34.5)               85           53.0 (68.0--37.0)      −0.031   0.975
   ATE of waist anticlockwise        85              46.0 (63.5--33.5)               85           45.0 (60.5--35.0)      −0.067   0.947
  Physical parameters                                                                                                             
   BMI, kg/m^2^                      85              25.37±3.19                      85           25.04±3.05             0.686    0.494
   WHR                               85              0.90±0.07                       85           0.90±0.07              0.351    0.726
   Flexibility, cm                   85              −2.67±11.32                     85           −3.60±12.37            0.513    0.609
  Psychological outcomes                                                                                                          
   SF-36 scales                                                                                                                   
   SF-36 (PCS)                       85              81.00 (87.88--66.75)            85           72.50 (83.25--56.50)   −2.763   0.006
   SF-36(MCS)                        85              85.25 (92.00--72.96)            85           81.75 (90.75--65.52)   −1.694   0.090
   Quality of sleep (PSQI)           85              6.0 (9.0--4.0)                  85           6.0 (9.0--4.0)         −0.642   0.521
   Mood, (POMS-SF)                   85              93.0 (106.0--82.0)              85           94.0 (115.0--80.5)     −0.165   0.869

AOD, aortic diameter; ATE, average track error; BMI, body mass index; FBG, fasting blood glucose; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; HCY, homocysteine; HDL, high-density lipoprotein; IVST, interventricular septum thickness; LAD, left atrial diameter; LDL, low-density lipoprotein; LVAWT, left ventricular anterior wall thickness; LVDD, left ventricular diastolic diameter; LVEF, left ventricular ejection fraction; LVPWT, left ventricular posterior wall thickness; MCS, mental component summary score; MPAD, main pulmonary artery diameter; MVV, maximal voluntary ventilation; PCS, physical component summary score; POMS-SF, Profile of Mood States Short Form; PSQI, Pittsburgh Sleep Quality Index; RAD, right atrial diameter; RVID, right ventricle internal diameter; TC, total cholesterol; TG, triglyceride; VC~max~, maximum vital capacity; WHR, waist-to-hip ratio.

Discussion {#s3}
==========

Tai Chi is rooted in the traditional Chinese Taoist philosophy, and it is well known for its slow and graceful movements.[@R43] Tai Chi exercises have been practiced for centuries in China for health promotion due to its inter-relatedness of mind, body and spirit, as well as the belief that human existence should be in harmony with nature at all times.[@R44] In recent years, it has been gradually gaining popularity in Western societies. Research has shown that Tai Chi might be helpful for health-related fitness, by reducing blood pressure, controlling blood lipids and decreasing blood glucose,[@R45] [@R46] as well as improving balance control,[@R47] cardiopulmonary function,[@R48] quality of sleep and quality of life.[@R49] However, most of the recent systematic reviews' results have suggested that larger scale studies with more participants and longer observation periods are necessary to further confirm and illuminate the effectiveness of Tai Chi.[@R50] [@R51]

This is a randomised, parallel, controlled trial to evaluate the effectiveness of Tai Chi on reducing ischaemic stroke risk in people in the elderly community who have risk factors for ischaemic stroke. Its strengths include its rigorous design (RCT), target population (elderly community at high risk of ischaemic stroke) and emphasis on the protective effects of Tai Chi against ischaemic stroke risk. This paper describes the design, intervention development, baseline participants' demographics, study flow of the trial and baseline comparison, of primary and secondary outcomes between the Tai Chi and control groups. The baseline results suggested that no significant differences were found in demographics or primary and secondary outcomes when these comparisons were made, and a randomised, parallel, controlled design could provide good balance between the two groups. The results provided by the study will constitute good evidence for the protective effect of Tai Chi against ischaemic stroke in the elderly community at high risk for ischaemic stroke.

A limitation of the study is the primary outcome measurement. Theoretically, the incidence of ischaemic stroke in the target population is the optimal measurement of the protective effects of Tai Chi on ischaemic stroke risk. If so, this trial will require a much longer observation period, even several years, and a much larger sample size. However, due to limitations of study funding, we have selected cerebral haemodynamic parameters to assess the possible risk of ischaemic stroke. Although studies have indicated that cerebral haemodynamic parameters were associated with vascular inflammation and atherothrombotic infarction and were strong independent predictive factors,[@R52] they are still indirect and non-clinical end points for judging the effectiveness of Tai Chi for ischaemic stroke risk. In addition, because the transtemporal window is easily closed in elderly adults, especially older women, it usually causes poor ultrasonic transmission signals with much missing data, which can lead to some selection bias in evaluating cerebrovascular function. Another limitation of the protocol is that the participants screened might not be representative of the typical population. Because almost all of the participants come from the same community, living in an area close to the hospital, they might possibly have some differences from the target population. In addition, in the inclusion criteria, we defined 55--70 years of age as being elderly based on the current retirement age in China, which includes ages younger than the chronological age of over 60 years, which is accepted in many developed countries as a definition of elderly.

In summary, this trial demonstrates the necessity of preventing stroke in the older community population with a high risk of ischaemic stroke and the feasibility, utility and convenience of practicing Tai Chi. This study has the potential to provide information on the benefits of Tai Chi training to prevent ischaemic stroke risk in the elderly community population with risk factors for ischaemic stroke. If the intervention proves to be effective, the evidence-based findings will be available to the elderly community population with risk factors for ischaemic stroke. Further, we believe that these findings might also be suitable for other elderly people.
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